Literature DB >> 15325809

A coxib a day won't keep the doctor away.

Eric J Topol1, Gary W Falk.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15325809     DOI: 10.1016/S0140-6736(04)16906-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors:  Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

2.  Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2005-06-11

3.  The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry.

Authors:  Alex Cahana; Alexandre Mauron
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

4.  Do selective cyclo-oxygenase-2 inhibitors have a future?

Authors:  Bernard Bannwarth
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin- and AMPKalpha-independent manner.

Authors:  E Alpert; A Gruzman; B Lardi-Studler; G Cohen; R Reich; S Sasson
Journal:  Diabetologia       Date:  2006-01-31       Impact factor: 10.122

Review 6.  Clinical use and pharmacological properties of selective COX-2 inhibitors.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

7.  Inadequate use of preventive strategies in patients receiving NSAIDs.

Authors:  I Francetic; M Bilusic; V Macolic-Sarinic; M Huic; I Mercep; K Makar-Ausperger; V Erdeljic; S Mimica; I Baotic; P Simic
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 8.  Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials.

Authors:  P A Scott; G H Kingsley; C M Smith; E H Choy; D L Scott
Journal:  Ann Rheum Dis       Date:  2007-03-07       Impact factor: 19.103

9.  Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis.

Authors:  Louise Profit; Paul Chrisp
Journal:  Core Evid       Date:  2007-11-30

Review 10.  Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing.

Authors:  Afaf A El-Malah; Magdy M Gineinah; Pran Kishore Deb; Ahdab N Khayyat; Monika Bansal; Katharigatta N Venugopala; Anfal S Aljahdali
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.